Literature DB >> 18458872

Twenty-four hour insulin secretion and beta cell NEFA oxidation in type 2 diabetic, morbidly obese patients before and after bariatric surgery.

S Salinari1, A Bertuzzi, A Iaconelli, M Manco, G Mingrone.   

Abstract

AIMS/HYPOTHESIS: We have previously demonstrated that type 2 diabetes resolves after bariatric surgery. To study the role of NEFA in the prompt normalisation of beta cell glucose sensitivity, insulin secretion and beta cell glucose and lipid metabolism were investigated by a model of nutrient-stimulated insulin secretion using a multiple-meal test.
METHODS: Hourly glucose, C-peptide and NEFA were measured in nine morbidly obese, type 2 diabetic patients before and 1 week after bariatric surgery and in six matched healthy volunteers over 24 h. A mathematical model of glucose-NEFA comodulation of insulin secretion rate (ISR) was used to compute ISR and beta-oxidation. Insulin sensitivity was measured by an OGTT minimal model.
RESULTS: Beta cell sensitivity to glucose and NEFA was doubled after surgery, while the 24 h insulin secretion decreased from 277.1 +/- 144.4 to 198.0 +/- 107.6 nmol/m(2) (p < 0.02). Insulin sensitivity was restored. The beta-oxidation rate of beta cells was completely normalised (from 0.032 +/- 0.012 x 10(-12) to 0.103 +/- 0.031 x 10(-12) mmol/min per cell, p < 0.005). The best predictor of beta cell function improvement was the duration of diabetes. CONCLUSIONS/
INTERPRETATION: Bariatric surgery in type 2 diabetes restores beta-oxidation in beta cells, doubles glucose-NEFA sensitivity and reverses diabetes. It is likely that ISR is reduced to match insulin-sensitivity normalisation, in spite of no significant reduction in NEFA levels. We hypothesise that insulin sensitivity normalisation might appear as a consequence of nutrient exclusion from proximal intestinal transit, and that secondarily the need for insulin secretion diminishes. The insulin sensitivity increase is much higher than usually obtained by insulin-sensitising agents and is independent of weight changes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18458872     DOI: 10.1007/s00125-008-1007-y

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  48 in total

1.  Insulin sensitivity by oral glucose minimal models: validation against clamp.

Authors:  Chiara Dalla Man; Kevin E Yarasheski; Andrea Caumo; Heather Robertson; Gianna Toffolo; Kenneth S Polonsky; Claudio Cobelli
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-07-12       Impact factor: 4.310

2.  Leptin pulsatility in formerly obese women.

Authors:  Geltrude Mingrone; Melania Manco; Luigi Granato; Menotti Calvani; Antonio Scarfone; Elena Valera Mora; Aldo V Greco; Hubert Vidal; Marco Castagneto; Eleuterio Ferrannini
Journal:  FASEB J       Date:  2005-06-13       Impact factor: 5.191

Review 3.  The role of impaired early insulin secretion in the pathogenesis of Type II diabetes mellitus.

Authors:  R E Pratley; C Weyer
Journal:  Diabetologia       Date:  2001-08       Impact factor: 10.122

Review 4.  Fatty acid signaling in the beta-cell and insulin secretion.

Authors:  Christopher J Nolan; Murthy S R Madiraju; Viviane Delghingaro-Augusto; Marie-Line Peyot; Marc Prentki
Journal:  Diabetes       Date:  2006-12       Impact factor: 9.461

Review 5.  Role of fatty acids in the pathogenesis of insulin resistance and NIDDM.

Authors:  G Boden
Journal:  Diabetes       Date:  1997-01       Impact factor: 9.461

6.  Quantitative indexes of beta-cell function during graded up&down glucose infusion from C-peptide minimal models.

Authors:  G Toffolo; E Breda; M K Cavaghan; D A Ehrmann; K S Polonsky; C Cobelli
Journal:  Am J Physiol Endocrinol Metab       Date:  2001-01       Impact factor: 4.310

7.  Glucose-induced insulin hypersecretion in lipid-infused healthy subjects is associated with a decrease in plasma norepinephrine concentration and urinary excretion.

Authors:  C Magnan; C Cruciani; L Clément; P Adnot; M Vincent; M Kergoat; A Girard; J L Elghozi; G Velho; N Beressi; J L Bresson; A Ktorza
Journal:  J Clin Endocrinol Metab       Date:  2001-10       Impact factor: 5.958

8.  A review of body composition studies with emphasis on total body water and fat.

Authors:  H P Sheng; R A Huggins
Journal:  Am J Clin Nutr       Date:  1979-03       Impact factor: 7.045

9.  U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group.

Authors: 
Journal:  Diabetes       Date:  1995-11       Impact factor: 9.461

10.  NEFA-glucose comodulation model of beta-cell insulin secretion in 24-h multiple-meal test.

Authors:  Serenella Salinari; Alessandro Bertuzzi; Melania Manco; Geltrude Mingrone
Journal:  Am J Physiol Endocrinol Metab       Date:  2007-03-06       Impact factor: 4.310

View more
  12 in total

1.  Studies in insulin resistance following very low calorie diet and/or gastric bypass surgery.

Authors:  Jonathan Foo; Jeremy Krebs; Mark Thomas Hayes; Damon Bell; Donia Macartney-Coxson; Tony Croft; Richard Strawson Stubbs
Journal:  Obes Surg       Date:  2011-12       Impact factor: 4.129

Review 2.  Metabolic surgery for the treatment of type 2 diabetes in patients with BMI <35 kg/m2: an integrative review of early studies.

Authors:  M Fried; G Ribaric; J N Buchwald; S Svacina; K Dolezalova; N Scopinaro
Journal:  Obes Surg       Date:  2010-06       Impact factor: 4.129

3.  Enhancement of the incretin pathway in response to bariatric surgery is important for restoration of beta cell function.

Authors:  M Komatsu; T Aizawa
Journal:  Diabetologia       Date:  2008-11-27       Impact factor: 10.122

Review 4.  Could the improvement of obesity-related co-morbidities depend on modified gut hormones secretion?

Authors:  Carmine Finelli; Maria Carmela Padula; Giuseppe Martelli; Giovanni Tarantino
Journal:  World J Gastroenterol       Date:  2014-11-28       Impact factor: 5.742

5.  Differential Acute Impacts of Sleeve Gastrectomy, Roux-en-Y Gastric Bypass Surgery and Matched Caloric Restriction Diet on Insulin Secretion, Insulin Effectiveness and Non-Esterified Fatty Acid Levels Among Patients with Type 2 Diabetes.

Authors:  Felicity Thomas; Greg C Smith; Jun Lu; Richard Babor; Michael Booth; Grant Beban; J Geoffrey Chase; Rinki Murphy
Journal:  Obes Surg       Date:  2016-08       Impact factor: 4.129

Review 6.  Effects of bariatric surgery on glucose homeostasis and type 2 diabetes.

Authors:  David Bradley; Faidon Magkos; Samuel Klein
Journal:  Gastroenterology       Date:  2012-08-08       Impact factor: 22.682

Review 7.  The effect of gastrointestinal surgery on insulin resistance and insulin secretion.

Authors:  Marco Castagneto; Geltrude Mingrone
Journal:  Curr Atheroscler Rep       Date:  2012-12       Impact factor: 5.113

8.  First-phase insulin secretion restoration and differential response to glucose load depending on the route of administration in type 2 diabetic subjects after bariatric surgery.

Authors:  Serenella Salinari; Alessandro Bertuzzi; Simone Asnaghi; Caterina Guidone; Melania Manco; Geltrude Mingrone
Journal:  Diabetes Care       Date:  2008-11-25       Impact factor: 19.112

9.  Improvement in peripheral glucose uptake after gastric bypass surgery is observed only after substantial weight loss has occurred and correlates with the magnitude of weight lost.

Authors:  Guilherme M Campos; Charlotte Rabl; Sofia Peeva; Ruxandra Ciovica; Madhu Rao; Jean-Marc Schwarz; Peter Havel; Morris Schambelan; Kathleen Mulligan
Journal:  J Gastrointest Surg       Date:  2009-10-17       Impact factor: 3.452

10.  Restoring Insulin Secretion (RISE): design of studies of β-cell preservation in prediabetes and early type 2 diabetes across the life span.

Authors: 
Journal:  Diabetes Care       Date:  2013-11-05       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.